Ibtasam Wajid | Medicine | Best Researcher Award

Published on by Best Achievements

Mr. Ibtasam Wajid | Medicine | Best Researcher Award

Shenzhen University China | Pakistan

Ibtasam Wajid is a dedicated researcher currently pursuing a PhD in Biomedical Engineering at Shenzhen University, China, with a strong academic foundation in Health Informatics (MS, COMSATS University Islamabad) and Biochemistry (BS, Islamia University of Bahawalpur). Working under the supervision of Prof. Dr. Nadeem Javaid at Comsens Lab, COMSATS University, Islamabad, Ibtasam’s research focuses on the integration of machine learning and deep learning techniques in healthcare, particularly for cardiovascular disease prediction and medical data analysis. His expertise encompasses data science, biomedical signal processing, and artificial intelligence applications in clinical decision-making. He has contributed to publications and collaborative projects, with an h-index of 2, 4 published documents, and over 35 citations on Google Scholar, reflecting his growing influence in computational health research. His technical proficiency includes Python, R-Studio, LaTeX, SPSS, and QGIS, along with hands-on laboratory skills in molecular biology and medical imaging. Beyond research, he has organized workshops and mentored undergraduate students in innovative data-driven healthcare projects. His commitment to scientific advancement and multidisciplinary collaboration positions him as a promising researcher contributing to the future of intelligent healthcare systems.

Profile: Scopus | Google Scholar 

Featured Publications

shaq, S., Afzal, S., Usmani, S. A., Wajid, I., Aziz, A., Tahir, R., Ahmad, A., & Ullah, A. (2025). Inflammatory cell death and leukemia treatment. Critical Reviews in Oncology/Hematology, 104909.

 

Olga Golubnitschaja | Medicine | Best Researcher Award

Published on by Best Achievements

Prof. Dr. Olga Golubnitschaja | Medicine | Best Researcher Award

University Hospital | Friedrich-Wilhelms University of Bonn | Germany

Prof. Dr. Olga Golubnitschaja is an internationally recognized pioneer and world-leading authority in Predictive, Preventive, and Personalised Medicine (3PM), serving as the head of the world’s first 3PM initiative at the University Hospital of Bonn, Germany. She is the President of the European Association for Predictive, Preventive and Personalised Medicine (EPMA, Brussels), connecting experts across 56 countries, and Editor-in-Chief of the EPMA Journal and the SpringerNature book series “Advances in Predictive, Preventive & Personalised Medicine.” With an academic background in biomedicine and decades of leadership in shaping international biomedical research, Prof. Golubnitschaja has made transformative contributions to predictive diagnostics, targeted prevention, personalised treatments, and the integration of artificial intelligence in healthcare. She has authored over 400 peer-reviewed publications, with more than 200 indexed in PubMed, and published extensively in leading journals across disciplines such as oncology, cardiology, neurology, ophthalmology, endocrinology, and molecular medicine. Her cumulative impact is reflected in outstanding scientometric indicators, including an h-index of 46, 208 published documents, and 6,612 citations recorded by Scopus, in addition to a cumulative h-index of 70 on Google Scholar with more than 1,200 citations. These achievements highlight her exceptional influence in advancing innovative medical strategies, patient stratification, and cost-effective healthcare tailored to individual patient needs

Profiles: Scopus | Orcid | Google Scholar | Staff Page

Featured Publications

    • Golubnitschaja, O. (2022). Flavonoids exert potential in the management of hypertensive disorders in pregnancy. Pregnancy Hypertension, 29, 178–180.

    • Golubnitschaja, O. (2022). Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine — comprehensive effects of phytochemicals in primary, secondary and tertiary care. EPMA Journal, 13, 267–280.

    • Golubnitschaja, O. (2022). Anti-breast cancer effects of phytochemicals: Primary, secondary, and tertiary care. EPMA Journal, 13, 249–266.

    • Golubnitschaja, O. (2022). Mitochondrial health quality control: Measurements and interpretation in the framework of predictive, preventive, and personalized medicine. EPMA Journal, 13, 281–297.

    • Golubnitschaja, O. (2022). Prostate cancer treatment costs increase more rapidly than for any other cancer—How to reverse the trend? EPMA Journal, 13, 119–122.

Ji-Hyun Lee | Medicine | Best Researcher Award

Published on by Best Achievements

Prof. Ji-Hyun Lee | Medicine | Best Researcher Award

Prof. Ji-Hyun Lee, Seoul National University Hospital, South Korea.

🩺 Dr. Ji-Hyun Lee, MD, PhD, is a Clinical Associate Professor at Seoul National University Hospital specializing in Anesthesiology and Pain Medicine. With over 17 years of clinical and academic experience, she has published extensively in top medical journals 🧠📚. Her research focuses on pediatric anesthesia, noninvasive monitoring, and critical care innovation. Dr. Lee is recognized for her clinical excellence, impactful studies, and commitment to advancing patient safety and care standards globally 🌍👩‍⚕️.

Profile

Scopus Profile

Orcid Profile

🎓 Early Academic Pursuits

Dr. Ji-Hyun Lee embarked on her academic journey at the College of Medicine, Seoul National University, where she earned her Bachelor’s degree in Medicine (2007). She deepened her expertise with a Master’s (2013) and later a PhD (2015)c in Anesthesiology and Pain Medicine from the same prestigious institution. 🎓 Her dedication to pediatric anesthesiology was evident early on, setting the foundation for a successful clinical and academic career.

💼 Professional Endeavors

Dr. Lee has been affiliated with Seoul National University Hospital since 2007, progressing from intern to Clinical Associate Professor by 2020. Her roles have included Resident, Fellow, Research Professor, Clinical Assistant Professor, and now Clinical Associate Professor in the Department of Anesthesiology and Pain Medicine. Her trajectory reflects consistent excellence and leadership in clinical practice and teaching. 🩺📚

🔬 Contributions and Research Focus On Medicine 

Dr. Lee’s prolific research spans pediatric anesthesiology, cardiac anesthesia, neurotoxicity of anesthetic agents, and non-invasive monitoring techniques. She has contributed to over 30 peer-reviewed publications in top-tier journals including British Journal of Anaesthesia, Paediatric Anaesthesia, and Anesthesia & Analgesia. Her work on fluid responsiveness, central venous catheterization, and hemodynamic monitoring has practical implications in pediatric surgical care. 🧪🧠

🌍 Impact and Influence

Her innovative research has significantly influenced pediatric anesthetic protocols both in Korea and internationally. By addressing clinical risks and improving procedural safety, Dr. Lee has enhanced outcomes in critically ill children. Her interdisciplinary collaborations amplify her reach in both clinical research and education. 👩‍⚕️✨

🧠 Research Skills

Dr. Lee exhibits exceptional skills in clinical trial design, data analysis, ultrasound and imaging techniques, and perioperative monitoring. Her ability to translate clinical challenges into research questions has led to impactful findings, especially in pediatric anesthetic safety. She is proficient in working with transesophageal echocardiography, neurodevelopmental safety evaluations, and real-time hemodynamic assessments. 🔍💡

🏅 Awards and Honors

While specific awards are not listed, Dr. Lee’s career advancement and extensive publication record point to peer recognition and institutional esteem. Her role as Clinical Associate Professor at one of Korea’s top medical centers is itself a mark of honor. 🎖️🇰🇷

🏛️ Legacy and Future Contributions

Dr. Ji-Hyun Lee is poised to leave a lasting legacy in pediatric anesthesiology. Her ongoing contributions are likely to redefine anesthesia safety protocols in children and inspire innovations in perioperative care technologies. As an educator, she continues to mentor the next generation of clinician-scientists. Her future work promises to integrate AI-driven diagnostics and personalized anesthesia care for pediatric patients. 🚀🧬

Publications Top Notes

📘 “Response to ‘Comment on Usefulness of C-curved stylet for intubation with the C-MAC® Miller videolaryngoscope in neonates and infants'”
Journal: Korean Journal of Anesthesiology
Year: 2024
🔗 DOI: 10.4097/kja.23842

🩺 “Ultrasound‐guided selective supraclavicular nerve block for postoperative pain control in children…”
Journal: Pediatric Anesthesia
Year: 2024
🔗 DOI: 10.1111/pan.14745

😷 “Perioperative Respiratory-Adverse Events Following General Anesthesia Among Pediatric Patients After COVID-19”
Journal: Journal of Korean Medical Science
Year: 2023
🔗 DOI: 10.3346/jkms.2023.38.e349

💨 “Effect of tidal volume change on pressure‐based prediction of fluid responsiveness in children”
Journal: Pediatric Anesthesia
Year: 2023
🔗 DOI: 10.1111/pan.14751

👶 “Usefulness of C-curved stylet for intubation with the C-MAC® Miller videolaryngoscope in neonates and infants”
Journal: Korean Journal of Anesthesiology
Year: 2023
🔗 DOI: 10.4097/kja.22716

🫀 “Evaluation of Portal, Splenic, and Hepatic Vein Flows in Children Undergoing Congenital Heart Surgery”
Journal: Journal of Cardiothoracic and Vascular Anesthesia
Year: 2023
🔗 DOI: 10.1053/j.jvca.2023.04.010

💧 “Association of the perfusion index with postoperative acute kidney injury: a retrospective study”
Journal: Korean Journal of Anesthesiology
Year: 2023
🔗 DOI: 10.4097/kja.22620

🧠 “Learning curve of fiberoptic bronchoscope-guided tracheal intubation through supraglottic airway device…”
Journal: Korean Journal of Anesthesiology
Year: 2023
🔗 DOI: 10.4097/kja.22582

👁️ “Comparison of effects of volatile and intravenous anesthetics on pupillary function during general anesthesia in children”
Journal: Pediatric Anesthesia
Year: 2023
🔗 DOI: 10.1111/pan.14671

💉 “Pharmacokinetics of dexmedetomidine in pediatric patients undergoing cardiac surgery with cardiopulmonary bypass”
Journal: Pediatric Anesthesia
Year: 2023
🔗 DOI: 10.1111/pan.14626

🔄 “Reversal of rocuronium‐induced intense neuromuscular blockade by sugammadex in Korean children”
Journal: Clinical and Translational Science
Year: 2023
🔗 DOI: 10.1111/cts.13429

🧬 “Response of internal carotid artery blood flow velocity to fluid challenge under general anesthesia in pediatric patients with moyamoya disease”
Journal: Pediatric Anesthesia
Year: 2022
🔗 DOI: 10.1111/pan.14558

📉 “Critical incidents associated with pediatric anesthesia: changes over 6 years at a tertiary children’s hospital”
Journal: Anesthesia and Pain Medicine
Year: 2022
🔗 DOI: 10.17085/apm.22164

🧍‍♂️ “Performance time of anesthesiology trainees for cricothyroid membrane identification… using ultrasonography”
Journal: Pediatric Anesthesia
Year: 2022
🔗 DOI: 10.1111/pan.14451

Lingzhi Zhong | Medicine | Best Researcher Award

Published on by Best Achievements

Dr. Lingzhi Zhong | Medicine | Best Researcher Award 

Dr. Lingzhi Zhong PLA General Hospital, China.

Dr. Lingzhi Zhong is an Assistant Research Fellow and Lecturer at the PLA General Hospital 🏥. She holds a Ph.D. in Pathology and Physiology from Jilin University 🎓. Her research specializes in tissue repair and regenerative medicine 🧬. With over ten peer-reviewed publications, several patents, and editorial roles, she has made remarkable strides in wound healing innovations 💡. Dr. Zhong is also a member of the Microcirculation Committee and continues to drive impactful biomedical research with passion and precision 🔬✨.

🌟 Professional Profile

Orcid Profile

🎓 Early Academic Pursuits

Lingzhi Zhong began her academic journey with a Ph.D. in Pathology and Physiology from Jilin University School of Basic Medicine. During her formative years, she cultivated a strong foundation in medical sciences, with a growing interest in tissue repair and regenerative medicine. Her rigorous academic training laid the groundwork for a prolific research career that would later evolve into impactful scientific contributions.

💼 Professional Endeavors

Dr. Zhong currently serves as an Assistant Research Fellow and Lecturer at the Department of Basic Medicine, PLA General Hospital. With over a decade of research experience, she is actively involved in the scientific community, both as a lecturer and investigator. Her professional trajectory also includes editorial roles, contributing as a board member and associate editor for esteemed academic publications. Her academic service underscores her dedication to both teaching and research leadership.

🔬 Contributions and Research Focus On Medicine 

Dr. Zhong’s research centers around wound healing, tissue regeneration, and anti-scarring innovations. One of her notable breakthroughs includes the reprogramming of fibroblasts into endothelial cells using forskolin, a discovery funded by the Youth Project of the National Natural Science Foundation of China. She has also explored the potential of arsenic compounds in inhibiting scar formation—an unprecedented approach in wound repair research. Her multi-faceted innovations bridge chemistry, biology, and medicine.

🌍 Impact and Influence

Her work has made a tangible impact on regenerative medicine, advancing strategies for scar reduction and chronic wound healing. The development of composite dressings and chitosan-based therapeutics reflects her commitment to clinical translation and improved patient outcomes. She has co-authored over ten SCI-indexed publications, each contributing to a better understanding of biological healing processes and therapeutic design.

🏆 Awards and Honors

Dr. Zhong has earned recognition for her pioneering research in regenerative medicine and wound care. Her nomination for the Best Researcher Award underlines her innovative edge and dedication to biomedical science. Her editorial appointments and participation in professional societies like the Microcirculation Committee of the Society of Integrated Traditional Chinese and Western Medicine further reinforce her respected standing in the scientific community.

📚 Books, Patents, and Innovation

Her contributions extend beyond journal articles. Dr. Zhong is currently co-authoring a book titled “Progress in Life Sciences”. She also holds three patents in advanced biomedical technologies:

  1. Composite dressing for skin healing

  2. Chemical induction of dermal fibroblasts

  3. Chitosan-taurine microbeads for scar reduction

These innovations demonstrate her translational research impact, turning lab discoveries into therapeutic applications.

🚀 Legacy and Future Contributions

Lingzhi Zhong is at the forefront of translational regenerative medicine. Her work continues to inspire new methods for scar-free healing, and she remains dedicated to developing novel bioactive delivery systems. With continued research, editorial leadership, and interdisciplinary collaboration, Dr. Zhong is poised to make lasting contributions to science and human health.

📚Publications Top Notes

  1. 🧴 Forskolin-loaded carboxymethyl chitosan and silk nanofiber hydrogels composite scaffolds improve skin regeneration
    International Journal of Biological Macromolecules, 2025

  2. 🧬 Chitosan-taurine nanoparticles cross-linked carboxymethyl chitosan hydrogels facilitate both acute and chronic diabetic wound healing
    International Journal of Biological Macromolecules, 2024

  3. 🧠 Potential pre-activation strategies for improving therapeutic efficacy of mesenchymal stem cells: current status and future prospects
    Stem Cell Research & Therapy, 2022

  4. 🐷 Characterization of the Skin Bacteriome and Histology Changes in Diabetic Pigs
    The International Journal of Lower Extremity Wounds, 2022

  5. 🌿 Promotive effects of four herbal medicine ARCC on wound healing in mice and human
    Health Science Reports, 2022

  6. 🔬 A New Target of the Four-Herb Chinese Medicine for Wound Repair Promoted by Mitochondrial Metabolism Using Protein Acetylation Analysis
    Medical Science Monitor, 2022

  7. 🔥 Macrophage Related Chronic Inflammation in Non-Healing Wounds
    Frontiers in Immunology, 2021

  8. 🧫 Biological approaches for hypertrophic scars
    International Wound Journal, 2020

  9. 🩹 Chitosan/LiCl composite scaffolds promote skin regeneration in full-thickness loss
    Science China Life Sciences, 2020

  10. 🧪 Sustained release of inhibitor from bionic scaffolds for wound healing and functional regeneration
    Biomaterials Science, 2020

  11. 💧 Bioactive Molecules for Skin Repair and Regeneration: Progress and Perspectives
    Stem Cells International, 2019

  12. 🕸️ Concentrated Conditioned Medium-Loaded Silk Nanofiber Hydrogels with Sustained Release of Bioactive Factors To Improve Skin Regeneration
    ACS Applied Bio Materials, 2019

  13. 🚫 Arsenic trioxide inhibits the differentiation of fibroblasts to myofibroblasts through NFE2L2 and Smad2/3
    Journal of Cellular Physiology, 2019

  14. 🧪 Comparative Proteomic Analysis of the Effect of the Four-Herb Chinese Medicine ANBP on Promoting Mouse Skin Wound Healing
    The International Journal of Lower Extremity Wounds, 2017

  15. 🧠 Arsenic Trioxide Activate Transcription of Heme Oxygenase-1 via NFE2L2
    International Journal of Medical Sciences, 2015

  16. 🦴 Heme oxygenase-1 silencing increases sensitivity of osteosarcoma MG63 cells to arsenic trioxide
    Molecular and Cellular Biochemistry, 2014